Jeremy Grantham's AMGN Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 4,642 shares of Amgen Inc. (AMGN) worth $1.52 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 37 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in AMGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2013, adding 602,464 shares. Largest reduction occurred in Q3 2014, reducing 1.27 M shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +397 | Add 9.35% | 4,642 | $282.20 |
| Q2 2025 | +481 | Add 12.78% | 4,245 | $279.21 |
| Q1 2025 | -673 | Reduce 15.17% | 3,764 | $311.55 |
| Q4 2024 | +928 | Add 26.45% | 4,437 | $260.64 |
| Q3 2024 | +3,509 | New Buy | 3,509 | $322.21 |
| Q4 2020 | -43,879 | Sold Out | 0 | $0.00 |
| Q3 2020 | -2,700 | Reduce 5.80% | 43,879 | $254.15 |
| Q2 2020 | -17,952 | Reduce 27.82% | 46,579 | $235.86 |
| Q1 2020 | +1,131 | Add 1.78% | 64,531 | $202.72 |
| Q4 2019 | -13,200 | Reduce 17.23% | 63,400 | $241.07 |
| Q3 2019 | -55,400 | Reduce 41.97% | 76,600 | $193.51 |
| Q2 2019 | -2,800 | Reduce 2.08% | 132,000 | $184.28 |
| Q1 2019 | -7,800 | Reduce 5.47% | 134,800 | $189.98 |
| Q4 2018 | +800 | Add 0.56% | 142,600 | $194.67 |
| Q3 2018 | +132,500 | Add 1424.73% | 141,800 | $207.29 |
| Q2 2018 | +2,400 | Add 34.78% | 9,300 | $184.62 |
| Q1 2018 | +4,900 | Add 245.00% | 6,900 | $170.43 |
| Q4 2017 | -200 | Reduce 9.09% | 2,000 | $174.00 |
| Q2 2017 | +200 | Add 10.00% | 2,200 | $172.27 |
| Q1 2017 | -499 | Reduce 19.97% | 2,000 | $164.00 |
| Q4 2016 | +100 | Add 4.17% | 2,499 | $146.06 |
| Q3 2016 | -400 | Reduce 14.29% | 2,399 | $166.74 |
| Q2 2016 | -151,216 | Reduce 98.18% | 2,799 | $152.20 |
| Q1 2016 | -201,848 | Reduce 56.72% | 154,015 | $149.93 |
| Q4 2015 | -223,563 | Reduce 38.58% | 355,863 | $162.33 |
| Q3 2015 | -49,534 | Reduce 7.88% | 579,426 | $138.32 |
| Q2 2015 | +129,113 | Add 25.83% | 628,960 | $153.52 |
| Q1 2015 | -526,304 | Reduce 51.29% | 499,847 | $159.85 |
| Q4 2014 | -965,869 | Reduce 48.49% | 1.03 M | $159.29 |
| Q3 2014 | -1.27 M | Reduce 38.91% | 1.99 M | $140.46 |
| Q2 2014 | -29,329 | Reduce 0.89% | 3.26 M | $118.37 |
| Q1 2014 | +167,503 | Add 5.36% | 3.29 M | $123.34 |
| Q4 2013 | +453,895 | Add 17.01% | 3.12 M | $114.16 |
| Q3 2013 | +602,464 | Add 29.16% | 2.67 M | $111.94 |
| Q2 2013 | +2.07 M | Add 0.00% | 2.07 M | $98.66 |
Jeremy Grantham's Amgen Investment FAQs
Jeremy Grantham first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 2,066,387 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Amgen Inc. (AMGN) for 37 quarters since Q2 2013.
Jeremy Grantham's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 2,066,387 shares worth $203.87 M.
According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 4,642 shares of Amgen Inc. (AMGN), valued at approximately $1.52 M.
As of the Q4 2025 filing, Amgen Inc. (AMGN) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Amgen Inc. (AMGN) was 3,290,249 shares, as reported at the end of Q1 2014.